Skip to main content
Article
Cardiovascular Differences Between Phenylpropanolamine and Its Related Norephedrine Isomers in the Rat
Journal of Pharmaceutical Sciences (1987)
  • Fernando A Moya, Pfizer Pharmaceuticals
  • P.J. Kiritsy, Pfizer Pharmaceuticals
Abstract
Various studies have confused the norephedrine and norpseudoephedrine isomers with phenylpropanolamine (PPA, d,l-norephedrine). This confusion has led us to investigate the pharmacological activity of the norephedrine (NOR) and norpseudoephedrine (NORP) isomers in the cardiovascular system of the urethane:chloralose anesthetized rat. Following intravenous administration, in a cumulative-dose fashion, l-NOR and PPA were the most potent compounds at increasing arterial blood pressure, while d-NOR, d-NORP, and l-NORP were relatively inactive at the doses tested (0.31-10 mg/kg). Prior reserpinization did not significantly shift the cumulative dose-response curves for l-NOR and PPA. Repetitive injections of PPA and l-NOR (1 mg/kg, 4 doses at 5-min intervals) failed to produce tachyphylaxis to the pressor response. On the other hand, when d-NORP was administered in a similar fashion, tachyphylaxis to the second and subsequent doses was observed. These studies demonstrate that significant mechanistic differences exist between these norephedrine isomers.
Keywords
  • Blood Pressure,
  • Phenylpropanolamine,
  • Reserpine,
  • Optical Rotation
Publication Date
1987
DOI
10.1002/jps.2600760206
Citation Information
Fernando A Moya and P.J. Kiritsy. "Cardiovascular Differences Between Phenylpropanolamine and Its Related Norephedrine Isomers in the Rat" Journal of Pharmaceutical Sciences Vol. 76 Iss. 2 (1987) p. 114 - 116 ISSN: 0022-3549
Available at: http://works.bepress.com/fernando-moya/2/